Purchase Order 75N95023P00701
Award Date
9/1/23
Potential Completion Date
8/31/24
Potential Value
$25K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Dexorgen Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20879, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Codex Biosolutions Inc. Research and Development Division, doing business as Codex Biosolutions Inc., has been awarded a $18,400 firm fixed-price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide cell line generation services. The contract has a period of performance of September 1, 2023 through August 31, 2024 and will be performed in Gaithersburg, Maryland. No set-aside designation or subcontractors were indicated. The award...
This is a $29,400 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. Codex Biosolutions is a minority-owned, small disadvantaged business that specializes in advanced biotechnological research, particularly in cell line development, genetic engineering, and translational science support. The contract,...
This $18,000 firm fixed price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. Codex Biosolutions provides cell-based assay products and services to support research and development activities for government agencies, pharmaceutical companies, and other institutes. Under this contract, Codex is tasked with delivering specialized cell lines,...
This contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. The $18,060 firm fixed-price purchase order is for screening services to identify small molecule antagonists of the GPR17 receptor, which is involved in various diseases. Codex Biosolutions specializes in cell-based assays and has received numerous NIH contracts for research and...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Codex Biosolutions Inc., a minority-owned small disadvantaged business, to identify cellular factors that impact the production of a full-length HIV-1 envelope trimer without altering its native antigenic properties. The $599,424.00 firm-fixed-price contract is funded through the Small Business Innovation Research (SBIR) program and...
Codex Biosolutions Inc. has been awarded a firm fixed price purchase order valued at $22,620 by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health within the Department of Health and Human Services, to deliver an EXPI293 stable cell line overexpressing HTLV envelope protein in support of NIAID's efforts to develop treatments and preventions for infectious diseases. The research and development will be conducted by Codex...
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $35,025 firm fixed price purchase order to Codex Biosolutions Inc. under a non-competitive solicitation. Codex will generate a stable P/Q type calcium channel CaV2.1 cell line by cloning specified channel proteins into HEK293 cells and introducing an additional channel to control calcium flux, as described in the attached statement of work. The one-year contract has a period of performance from...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded Codex Biosolutions Inc., a small disadvantaged and minority-owned business, a firm fixed-price Small Business Innovation Research (SBIR) Phase I contract for the "DEVELOPMENT OF NOVEL PDE4B INHIBITORS TO TREAT ALCOHOL USE DISORDER" worth $224,656.00. As the prime contractor, Codex Biosolutions will provide specialized bioengineering, genomic...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,000 firm fixed price purchase order to 10X Genomics, Inc. for products and/or services to be delivered between September 25, 2023 and October 24, 2023. 10X Genomics, located in Rockville, Maryland, will serve as the prime contractor on this contract, which has been set aside for total small businesses. No additional details were provided on...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (HHS-NIH-NCATS) awarded a $1,579,540 firm fixed price delivery order to Axle Informatics, LLC of Potomac, Maryland. The order is to provide research associate program services from January 10, 2023 through January 9, 2024. No subcontractors were identified. The delivery order will support HHS-NIH-NCATS's mission to advance translational sciences and reduce barriers...